Video: Pluristem Says Its Placental Stem Therapy Offers "Off The Shelf" Promise
This article was originally published in The Pink Sheet Daily
Executive Summary
Pluristem Therapeutics Chairman and CEO Zami Aberman explains how stem cell therapy will shape the industry, in a recent interview at the Biotech Showcase.
You may also be interested in...
Pluristem Fast Forwards Placental Cell Therapy Into US-EU Pivotal Trial
Off-the-shelf placental cell therapy for peripheral artery disease will move from Phase I to registration stage study in US and Europe in early 2017, following “positive feedback” from FDA.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.